- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
January 31st, 2005
Anadis Ltd and Starpharma Holdings Limited announced today that they have established a partnership to investigate applications of their combined technologies to respiratory protection and biodefense.
This research involves the use of polyclonal antibodies, harvested from bovine colostrum and combined with Starpharma’s nano-scale dendrimer molecules to provide immediate short term respiratory protection from airborne biological agents such as Anthrax and Plague.
|Related News Press|
Nanoantenna lighting-rod effect produces fast optical switches October 24th, 2016
New nanomedicine approach aims to improve HIV drug therapies October 24th, 2016